Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Raphael E. Pollock
Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes - Nature Communications
Abstract Given their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340 sarcoma tumor specimens. We identify recurrent somatic mutations and observe an increased mutational burden in metastatic vs. primary samples (p < 0.001).
Unlocking the Potential of ctDNA in Sarcomas: A Review of Recent Advances
1. Background 1.1. Sarcoma Introduction Soft tissue sarcomas (STSs) are rare malignancies of mesenchymal origin, accounting for approximately 1% of adult cancers, with an estimated 13,500 new cases diagnosed in 2020 in the United States [1]. STSs constitute a heterogeneous and complex group of tumors with around 100 different histologic and molecular subtypes and variable clinical behavior [2]. An estimated 50% of patients with metastatic STS die within 18 months of their initial diagnosis [1,2].
Phosphorylation of IWS1 by AKT maintains liposarcoma tumor heterogeneity through preservation of cancer stem cell phenotypes and mesenchymal-epithelial plasticity | Oncogenesis
Abstract Chemotherapy remains the mainstay of treatment for patients with advanced liposarcoma (LPS), but response rates are only 25% and the overall survival at 5 years is dismal at 20–34%. Translation of other therapies have not been successful and there has been no significant improvement in prognosis for nearly 20 years.
Morbidity and Mortality after Surgery for Retroperitoneal Sarcoma
This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessReview by Samantha M. Ruff , Valerie P. Grignol , Carlo M. Contreras , Raphael E. Pollock and Joal D. Beane * Division of Surgical Oncology, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA * Author to whom correspondence should be addressed. Curr. Oncol.
Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma - Nature Communications
Abstract There are more than 70 distinct sarcomas, and this diversity complicates the development of precision-based therapeutics for these cancers. Prospective comprehensive genomic profiling could overcome this challenge by providing insight into sarcomas’ molecular drivers. Through targeted panel sequencing of 7494 sarcomas representing 44 histologies, we identify highly recurrent and type-specific alterations that aid in diagnosis and treatment decisions.
50 years of cancer care innovation at The Ohio State University
RP: Perhaps the most significant overall advance is a more thorough understanding of molecular genetics. Discoveries in this discipline have illuminated biological changes that can cause normal cells to become cancerous. Cancer fundamentally arises from the body’s failure to properly regulate cell growth, so it’s critical to know how normal cells function and what goes awry within the cell to cause cancer.
Being Both a Cancer Provider and a Cancer Survivor Is a Rare Privilege
If there is a silver lining in the cloud, it is in a newfound opportunity to bring a personal experience–based authenticity to the clinic. By Raphael E. Pollock, MD, PhD, as told to Jo Cavallo July 10, 2021 Advertisement Perhaps my 35-year career as a surgical oncologist and researcher specializing in soft-tissue sarcomas should have prepared me to recognize the signs of chronic lymphocytic leukemia (CLL) when they first appeared a few days before Christmas in 2016, but it did not.
A Case of Acute Iliocaval Thrombosis in the Setting of a Suprarenal Inferior Vena Cava Saccular Aneurysm
Publication HistoryPublished online: August 06, 2018Accepted: May 15, 2018; Received: March 1, 2018;
Multidisciplinary management of soft tissue sarcoma
Multidisciplinary management of soft tissue sarcoma Authors: William W. Tseng, Cheng-Hua Luo, Raphael E. Pollock Abstract Soft tissue sarcoma (STS) is a rare disease that represents 1% of all solid tumors in adults and encompasses over 50–70 different histologic subtypes, each with distinct genetic aberrations, clinical behavior and response to treatment.
Farewell, with gratitude
Abstract Dr. Raphael Pollock welcomes a new Editor-in-Chief and bids Cancer farewell.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Raphael E.
Contact Raphael E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack